Tradestie Institutional Equity Comparison Engine

MBRX vs CNSY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MBRX Overall Edge

MBRX Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Moleculin Biotech, Inc. (MBRX) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, MBRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CNSY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MBRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNSY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MBRX
MBRX N/M vs CNSY N/M Fwd P/E
Growth & Margin Winner MBRX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner MBRX
1Y +1547.9% vs -79.5% ยท 52W Pos 73% vs 8%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBRX NASDAQ
Moleculin Biotech, Inc.
Pharmaceutical Preparations
$7.48
-4.96% 1D
Market Cap $7.9M
1M Return +2567.62%
1Y Return +1547.94%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 24.0 Fund 33.0 Flow 50.0 Mom 40.0
CNSY US Equity
CNSY
Institutional Equity
$0.72
-24.24% 1D
Market Cap N/A
1M Return -57.65%
1Y Return -79.55%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MBRX +1547.94% CNSY -79.55% Spread: +1739.55 pp (MBRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MBRX TTM Op. Margin: 0.0% CNSY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBRX vs CNSY. Trailing 12-month operating profitability (MBRX 0.0% vs CNSY N/A) and valuation multiples (MBRX N/M vs CNSY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MBRX (7) vs CNSY (2)
Institutional Metric MBRX CNSY Criterion Row Winner
Market Capitalization Scale $7.9M N/A Larger Scale MBRX
Trailing P/E Ratio Valuation 0.0x N/M Lower Multiple MBRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth MBRX
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin MBRX
Net Profit Margin Profitability 0.0% N/A Higher Margin MBRX
Return on Equity (ROE) Capital Efficiency -1371.6% N/A Higher ROE MBRX
52-Week Range Position Momentum 73% ($0โ€“$10) 8% ($0โ€“$4) Stronger Trend MBRX
Beta / 30D Volatility Risk Regime 4.61ฮฒ ยท 7732% Vol 2.54ฮฒ ยท 228% Vol Lower Realized Risk CNSY
Unified Institutional Score Composite Signal 35.5 / 100 (SELL) 47.6 / 100 (HOLD) Higher Composite CNSY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MBRX vs CNSY Buy Guide
MBRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MBRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNSY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNSY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MBRX nor CNSY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.